DRKS00008551招募中不适用
Healthcare research multiple myeloma: latencies to diagnosis and treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients with multiple myeloma
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Healthcare research multiple myeloma - analysis in patient referring physician and participation satisfaction concerning the interdisciplinary CCF MM-tumorboard.C90.0Multiple myelomaDRKS00008573niversitätsklinikum Freiburg100
已完成
不适用
Healthcare research multiple myeloma (MM) - parameters to be assessed within the evaluation of the MM-Tumorboard (TB).C90.0Multiple myelomaDRKS00008587niklinik Freiburg299
已完成
不适用
High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentMultiple MyelomaRenal FailureNCT03234335Centre Hospitalier Universitaire de Saint Etienne50
进行中（未招募）
1 期
Impact of lenalidomide on immune cell expression in multiple myelomaMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2021-000987-31-FRCHU Rennes22
终止
不适用
CAR-T Cells Therapy in Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma(MM)NCT03473496Zhujiang Hospital2